Naproxen Tablet, Delayed Release
Product Images NDC 71205-060
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 71205-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Clinical Pahrmacology (0778e9f1 B341 448c Ba26 Cfa4370e8123 02)
This is a description of the pharmacokinetic properties of Naproxen delayed-release tablets and Naproxen tablets. The dosage for both is 500 mg twice a day. The text provides information on the maximum concentration (Cmax) of Naproxen in the bloodstream, the time it takes to reach Cmax (Tmax), and the area under the curve (AUC) over 12 hours. However, it is unclear from the text what these values indicate or how they relate to the efficacy or safety of the drug.*
Dosage And Administration (0778e9f1 B341 448c Ba26 Cfa4370e8123 03)
71205-060-60 (0778e9f1 B341 448c Ba26 Cfa4370e8123 04)
This is a medication called "Naproxen EC 375mg" made by InvaGen Pharmaceuticals, Inc. It comes in the form of 60 delayed-release (DR) tablets that are white, capsule-shaped, and biconvex. Each tablet contains 375mg of naproxen USP. It is important to dispense the medication guide provided separately to each patient. The tablets are debossed with the number '1' on one side. The item is packaged and sold by Proficient Rx LP in Thousand Oaks, CA. The lot number is 00000, and the expiry date is 00/00/00. It should be stored at 20°C to 25°C (68°F to 77°F) and should be kept out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.